NAD+ 1000mg Canada

Technical Specifications

Compound Name: Nicotinamide Adenine Dinucleotide (NAD+)
Quantity: 1000mg per vial
Format: Lyophilized or sterile powder (batch dependent)
Chemical Formula: C₂₁H₂₇N₇O₁₄P₂
Molecular Weight: Approximately 663.43 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational biochemical compound – laboratory research use only

NAD+ 1000mg Canada is supplied as a research-grade coenzyme intended exclusively for laboratory and analytical applications. Each vial contains 1000 milligrams of oxidized nicotinamide adenine dinucleotide prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.

Research Overview

Nicotinamide adenine dinucleotide (NAD+) is a central coenzyme found in all living cells. It plays a critical role in redox reactions, cellular metabolism, and energy production.

Research involving NAD+ 1000mg Canada typically focuses on mitochondrial function, oxidative phosphorylation, and cellular bioenergetics in laboratory environments. NAD+ participates in numerous metabolic pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and the electron transport chain, in experimental systems.

Scientific literature describes NAD+ as an essential cofactor in enzymatic reactions that transfer electrons during metabolic processes. It also serves as a substrate for sirtuins, poly(ADP-ribose) polymerases (PARPs), and other NAD+-dependent enzymes involved in DNA repair and gene regulation in research models.

NAD+ 1000mg Canada is supplied strictly for research purposes. All references to metabolic and cellular pathways reflect established biochemical findings and investigational research contexts and do not imply authorized therapeutic application of the research-grade material.

Mechanism Overview

NAD+ functions primarily as an electron carrier in redox reactions. In its oxidized form (NAD+), it accepts electrons and is reduced to NADH. This reversible conversion is fundamental to cellular energy metabolism in experimental systems.

Within the mitochondria, NADH donates electrons to the electron transport chain, facilitating ATP synthesis in laboratory models. Researchers studying NAD+ 1000mg Canada frequently assess NAD+/NADH ratios to evaluate metabolic efficiency and redox balance under controlled conditions.

In addition to its role in energy production, NAD+ serves as a substrate for sirtuin enzymes, which regulate gene expression through deacetylation. Laboratory investigations also explore NAD+ involvement in PARP-mediated DNA repair pathways and cellular stress responses.

Mechanistic descriptions are based on well-established biochemical principles and are presented for educational purposes only.

Clinical Development Context

NAD+ has been studied extensively in both preclinical and clinical research, with a focus on metabolism, ageing biology, and cellular stress responses. Pharmaceutical and supplement-related research has investigated NAD+ and its precursors under regulated conditions.

However, NAD+ 1000m,  supplied in research-grade form, is categorized strictly as an investigational laboratory compound. It is distinct from any authorized pharmaceutical or natural health product and is not approved by Health Canada as a therapeutic medication when provided as a research material.

Scientific interest in NAD+ biology continues across disciplines, including molecular biology, metabolic research, and gerontology.

Regulatory Status in Canada

NAD+ may be present in certain regulated research or pharmaceutical contexts when authorized under applicable frameworks.

NAD+ 1000mg, supplied from Canada as a laboratory compound, is classified separately as an investigational research material. It is not authorized by Health Canada for therapeutic or consumer use when provided in research format.

Handling, storage, and study of NAD+ 1000mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for maintaining regulatory compliance.

Molecular and Structural Notes

NAD+ is a dinucleotide composed of two nucleotides joined by their phosphate groups. One nucleotide contains an adenine base, and the other contains nicotinamide. The molecule functions as a key redox cofactor because it alternates between oxidized (NAD+) and reduced (NADH) states.

With a molecular weight of approximately 663.43 g/mol, NAD+ is relatively small compared to peptide-based research compounds. Its structure includes two phosphate groups, ribose sugars, and nitrogenous bases that enable electron transfer functions in metabolic pathways.

NAD+ 1000mg Canada is typically characterized using analytical techniques such as high-performance liquid chromatography (HPLC) and spectrophotometric assays to confirm identity and purity before distribution.

The lyophilized or sterile powder format supports compound stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is NAD+ 1000mg Canada studied for in research?
NAD+ 1000mg Canada is studied in laboratory settings to investigate cellular metabolism, mitochondrial function, and redox balance.

Is NAD+ approved for medical use in Canada?
Research-grade NAD+ 1000mg Canada is not authorized by Health Canada for therapeutic or consumer use when supplied as a laboratory compound.

What type of compound is NAD+?
It is a dinucleotide coenzyme involved in redox reactions and energy metabolism pathways.

Does NAD+ 1000mg Canada contain additives?
Unless specified in batch documentation, the vial contains only the research-grade NAD+ compound.

Can NAD+ 1000mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

NAD+ 1000mg Canada is an investigational research compound supplied solely for laboratory and analytical use. It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form.

Information provided on this page is educational in nature and based on publicly available scientific literature describing biochemical and investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of NAD+ 1000mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.